1. Home
  2. ATRO vs WVE Comparison

ATRO vs WVE Comparison

Compare ATRO & WVE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Astronics Corporation

ATRO

Astronics Corporation

HOLD

Current Price

$70.48

Market Cap

2.6B

Sector

Industrials

ML Signal

HOLD

Logo Wave Life Sciences Ltd.

WVE

Wave Life Sciences Ltd.

HOLD

Current Price

$7.15

Market Cap

2.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ATRO
WVE
Founded
1968
2012
Country
United States
Singapore
Employees
2700
N/A
Industry
Military/Government/Technical
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.6B
2.4B
IPO Year
N/A
2015

Fundamental Metrics

Financial Performance
Metric
ATRO
WVE
Price
$70.48
$7.15
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
16
Target Price
$86.00
$29.81
AVG Volume (30 Days)
359.6K
3.6M
Earning Date
05-12-2026
04-28-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$3,704,000.00
Revenue This Year
$14.92
N/A
Revenue Next Year
$8.81
$85.67
P/E Ratio
N/A
N/A
Revenue Growth
N/A
149.43
52 Week Low
$23.25
$5.02
52 Week High
$83.96
$21.73

Technical Indicators

Market Signals
Indicator
ATRO
WVE
Relative Strength Index (RSI) 46.30 37.93
Support Level $62.03 $6.93
Resistance Level $79.86 $7.67
Average True Range (ATR) 3.34 0.35
MACD -0.65 0.19
Stochastic Oscillator 32.60 31.19

Price Performance

Historical Comparison
ATRO
WVE

About ATRO Astronics Corporation

Astronics Corporation is a provider of technologies to the aerospace, defense, and electronics industries, offering high-performance electrical power generation and distribution systems, motion systems, lighting and safety systems, avionics products, systems certification, aircraft structures, and automated test systems. The company operates through two reportable segments, Aerospace and Test Systems. The Aerospace segment designs and manufactures products for the aerospace and defense industry and generates the majority of revenue, while the Test Systems segment designs, develops, manufactures, and maintains automated test systems for the aerospace and defense, communications, and mass transit industries. The company derives the majority of its revenue from the United States.

About WVE Wave Life Sciences Ltd.

WAVE Life Sciences Ltd is a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines also known as oligonucleotides, targeting ribonucleic acid (RNA), to transform human health. RNA medicines platform, PRISM, combines multiple modalities, chemistry innovation, and deep insights into human genetics to deliver scientific breakthroughs that treat both rare and prevalent disorders. Its toolkit of RNA-targeting modalities includes RNA editing, antisense silencing, and RNA interference, providing capabilities for designing and sustainably delivering candidates that optimally address disease biology. Its programs are for rare and prevalent diseases, including alpha-1 antitrypsin deficiency, obesity, Duchenne muscular dystrophy, and Huntington's disease.

Share on Social Networks: